News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

Inovio, Regeneron Plan Clinical Trial of Triple-Combo Immunotherapy for Brain Tumors

Al's Comment:

 I love this kind of combination - tries to cover all of the bases.  I wish them luck.  However, I am trying to change the system - it should be legal for a doctor to try this type of combination outside of trials.  What happens if they determine that a different drug might do better if they switch it out for the one they chose now?  It is back to the drawing board - design and set up another trial - waste a year or 2, and loads of money.  There is a better way.


Posted on: 05/11/2017

Inovio, Regeneron Plan Clinical Trial of Triple-Combo Immunotherapy for Brain Tumors

 

https://immuno-oncologynews.com/2017/05/11/inovio-and-regeneron-to-test-triple-combo-immunotherapy-in-brain-cancer-trial/

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740